NFKB1 and cancer: Our other study also indicated that constitutively activated IKKα, found in certain human cancers, including lung, liver, pancreatic, and ovarian cancers, can phosphorylate and direct CBP to bind preferentially to NF-κB but not p53, thereby favoring proliferation and survival over p53-dependent apoptosis [15].